Helsinki University Hospital adopts Stratipath Breast for AI-based risk profiling in Breast Cancer Care
Helsinki University Hospital (HUS), Finland’s largest healthcare provider and one of the leading academic medical centres in the Nordics, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, as a tool for prognostic testing in its clinical environment.